Request Deal Involvement

MeiHua to acquire amino acid and HMO businesses of Kyowa Hakko Bio from Kirin for JPY10.5bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Haiwen & Partners

legal advisors

Haiwen & Partners

Mori Hamada & Matsumoto

legal advisors

Mori Hamada & Matsumoto

K&L Gates

legal advisors

K&L Gates

Coleman Street Chambers

legal advisors

Coleman Street Chambers

Noerr

legal advisors

Noerr

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

or

Principals

KYOWA HAKKO BIO (AMINO ACIDS AND HMO BUSINESSES)

target

KYOWA HAKKO BIO (AMINO ACIDS AND HMO BUSINESSES)

MEIHUA HOLDING GROUP

bidder

MEIHUA HOLDING GROUP

KIRIN HOLDINGS COMPANY LIMITED

vendor

KIRIN HOLDINGS COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - MeiHua to acquire amino acid and HMO businesses of Kyowa Hakko Bio from Kirin for JPY10.5bn.